Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools?

Thrombosis Research
Lauro M VieiraMaria G Carvalho

Abstract

Tissue factor (TF) is the main physiological initiator of blood coagulation; it is membrane-bound on monocytes (mTF) and free in plasma (pTF). Abnormal expression of TF by monocytes has been implicated in various diseases. We therefore quantified monocytes expressing TF and pTF levels in patients with lower-limb deep venous thrombosis (DVT). DVT was confirmed by Duplex Scan. Blood mTF levels under resting condition (baseline), after incubation without (unstimulated) and with (stimulated) lipopolysaccharide (LPS), and total mTF levels were determined by flow cytometry using two analytical methods (Histogram and Quadrant-Statistics). Plasma TF levels were measured using an enzyme-linked immunoabsorbent assay (ELISA). Results were compared with age-matched controls. Histogram analysis in patients with DVT showed significantly elevated mTF levels for baseline, unstimulated and total mTF over controls. For Quadrant-Statistics, DVT patients also showed significantly raised baseline, unstimulated, stimulated and total mTF. Similarly, pTF levels were significantly raised in subjects with DVT compared to controls. Baseline mTF levels correlated with pTF levels by Histogram and Quadrant-Statistics analysis. Using the relative operating c...Continue Reading

References

Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A GuhaY Nemerson
Feb 1, 1972·Archives of Surgery·K Rabinov, S Paulin
May 1, 1993·The Journal of Clinical Investigation·J D MarmurM B Taubman
Apr 1, 1993·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·I R PeakeK Nicolaides
Oct 1, 1995·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·N YamadaK Suzuki
Aug 29, 1998·Thrombosis Research·H DeguchiK Suzuki
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·P L GiesenY Nemerson
Apr 21, 1999·Lancet·F R Rosendaal
Jun 15, 1999·Molecular Biotechnology·M J Jaroszeski, G Radcliff
Oct 29, 2000·Journal of Vascular Surgery·M H MeissnerD E Strandness
May 2, 2001·Seminars in Nuclear Medicine·B R Line
Jun 21, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·N FünfsinnW A Wuillemin
Apr 3, 2002·Archives of Internal Medicine·James KellyBeverley J Hunt
Nov 15, 2002·Thrombosis Research·Wee-Shian Chan, Jeffrey S Ginsberg
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·J Kelly, B J Hunt
Apr 22, 2004·QJM : Monthly Journal of the Association of Physicians·J KellyA Rudd
May 14, 2004·Journal of Thrombosis and Haemostasis : JTH·M MonrealJ Angel Jiménez

❮ Previous
Next ❯

Citations

Feb 15, 2014·The Journal of Infectious Diseases·Anita K McElroyChristina F Spiropoulou
Jun 10, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Letícia Gonçalves FreitasLuci Maria SantAna Dusse
Jun 23, 2011·Journal of Thrombosis and Haemostasis : JTH·M G BasavarajJ-B Hansen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.